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Abstract
Background: Natural Killer (NK) cells are the most abundant lymphocytes in the decidua during early gestation.
The interactions of NK cells with the extravillous cytotrophoblast have been associated with a normal spiral artery
remodeling process, an essential event for a successful pregnancy. Recent data indicate that alterations in the
amount of decidual NK (dNK) cells contribute to the development of preeclampsia (PE). Moreover, genetic studies
suggest that Killer Immunoglobulin-like Receptors (KIR) expressed in dNK cells influence the susceptibility to PE.
Although dNK cells have been well characterized during early pregnancy, they have been scarcely studied in the
third trimester of gestation. The aim of this work was to characterize dNK cells at the last trimester of gestation
and to analyze the KIR genotype of healthy and PE women.
Methods: Decidual samples were obtained during Caesarean section from control (n = 10) and PE (n = 9) women.
Flow cytometric analysis of CD3, CD56, CD16 and CD9 was used to characterize and quantify dNK cells in both
groups. Cell surface markers from decidual leukocytes were compared with PBMC from healthy donors.
KIR genotyping was performed in genomic DNA (control, n = 86; PE, n = 90) using PCR-SSP.
Results: The results indicate that dNK cells persist throughout pregnancy. They represented 20% of total leukocytes
in control and PE groups, and they expressed the same cell surface markers (CD3
-, CD56
+, CD16
- and CD9
+)a sd N K
in the first trimester of gestation. There were no significant differences in the percentage of dNK cells between
control and PE groups. The analysis of KIR gene frequencies and genotypes was not statistically different between
control and PE groups. The ratio of activating to inhibitory genes indicated that the overall inhibitory balance (0.2-
0.5) was more frequent in the PE group (control, 31.3% vs PE, 45.5%), and the activating balance (0.6-1.1) was more
frequent in the control group (control, 68.6% vs PE, 54.4%). However this difference was not significant.
Conclusion: We demonstrated the persistence of dNK cells in PE and control women at the third trimester of
pregnancy; these dNK cells had a similar phenotype to those found during early pregnancy. The predominance of
a KIR inhibitory balance in the PE group could be associated to the physiopathology of PE.
Background
Extravillous trophoblast invasion is a hallmark of normal
pregnancy. One of the main mechanisms that contribute
to normal spiral artery remodeling is the interaction
between decidual leukocytes and the extravillous cyto-
trophoblast. Dysregulation of these interactions is
associated with shallow endovascular cytotrophoblast
invasion of the spiral arteries, which is a key feature in
the pathogenesis of preeclampsia (PE) [1].
During normal early pregnancy, Natural Killer (NK)
cells are the most abundant population of leukocytes in
the decidua. It has been reported that NK cells represent
70% of the total decidual leukocyte population in the
first trimester of gestation [2,3]. Some authors propose
that this population is practically absent at the end of
pregnancy [2,4], but other researchers have identified
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term pregnancies [5-9].
It is well accepted that dNK cells differ from periph-
eral blood NK cells (pNK) in terms of their gene expres-
sion pattern, cell surface markers [10] and functions
[11]. Based on their cell surface markers, pNK cells are
divided into two subsets: CD56
dim CD16
+ (highly cyto-
toxic cells) and CD56
bright CD16
- (high cytokine secre-
tors) [12]. During early pregnancy, dNK cells have been
characterized as CD56
bright CD16
-,a sw e l la sb yt h e
expression of some exclusive proteins, e.g., Killer cell
Immunoglobulin like Receptors (KIR), CD9, CD151,
CD53 and a4b7 integrin [10,13,14].
Recently, Hanna et al found that dNK cells but not
pNK cells, mediate angiogenesis and fetal trophoblast
invasion through the release of chemokines and proan-
giogenic factors, including vascular endothelial growth
factor (VEGF) and placental growth factor (PLGF) [11].
In samples of decidua basalis in the earliest stages of
artery remodeling, Smith et al found dNK immunoposi-
tive cells for matrix metalloproteinase 7 and 9, suggest-
ing their participation in vascular remodeling in a
trophoblast independent stage [15].
Less evidence is available regarding the proportion,
cell surface markers and functions of dNK cells from
patients with PE, and the data are still controversial.
Some authors have found an increase in the number of
CD56
+ cells in the decidua of women with PE compared
to normal term pregnant women [16,17], while others
have found a decrease [18-20] or no differences in the
number of cells [21]. In this study, we analyzed NK cells
from the decidua of PE patients and normal term preg-
nant women.
Several functions of NK cells depend on a finely tuned
regulation by inhibitory and activating receptors. The
KIR family is one of the most important groups of
receptors expressed in NK cells, and HLA (histocompat-
ibility leukocyte antigens) are their foremost ligands.
The KIR family contains inhibitory (L) and activating (S)
receptors encoded by highly polymorphic loci. The
number and type of genes in these loci vary among indi-
viduals and haplotypes. Group A haplotype contains
only one stimulatory KIR gene (2DS4), whereas group B
haplotype contains various combinations of stimulatory
genes [22-24].
There is evidence about the participation of KIR in the
development of PE. The immune response in the
decidua greatly depends on the receptor-ligand recogni-
tion of maternal KIR genotypes and their fetal ligands
during the critical stages of uterine arterial remodeling.
In a Caucasian population it has been reported that the
KIR inhibitory genotype AA from pregnant women in
combination with HLA-C2 ligands in their babies, speci-
fically the presence of KIR2DL1, is associated with an
increased prevalence of PE [25]. In the present study we
analyzed the KIR genotype in normal and PE Mexican
women.
Methods
Patients and biological samples
For the analysis of decidual leukocytes, decidual tissue
samples were obtained by scraping off the mucosal sur-
face of the uterine cavity by curettage during cesarean
section, of women that had indicated or elective cesar-
ean sections at the third trimester of gestation (>36
weeks of gestation; control, n = 10; PE group, n = 9).
None of the subjects were in labor. Peripheral blood
samples were obtained from pregnant women in the
first trimester of gestation and from healthy non-preg-
nant women.
For the KIR genotyping study, maternal peripheral
blood samples were obtained by venipunction of the
forearm from eighty-six (n = 86) healthy pregnant
women (control group) and ninety (n = 90) preeclamp-
tic women (PE group).
This case-control study was performed with women
recruited consecutively from the Hospital of Gynecology
“Luis Castelazo” of the Mexican Social Security Institute,
in Mexico City. For the PE group, the diagnosis criteria
and classification were according to the American and
Royal College of Obstetricians and Gynecologists [26,27]
and the Mexican Ministry of Health guidelines [28].
Severe PE was defined as new-onset hypertension after
the 20
th week of pregnancy; systolic pressure ≥160 mm
Hg and/or diastolic ≥110 mm Hg, during a seven day
period on two occasions at least 6 hours apart, while the
patient is on bed rest; proteinuria ≥ 2gi na2 4hu r i n e
specimen; two or more persistent data of vasospasm
(e.g. oliguria of less than 500 mL in 24 h, seric creatinin
≥ 1.2 mg/dL, cerebral or visual disturbances, pulmonary
edema, epigastric or right upper-quadrant pain, impaired
liver function [AST ≥ 70/UI], thrombocytopenia
[<100,000 mm
3], cyanosis, intrauterine growth restric-
tion in the babies).
The control group consisted of healthy pregnant
women at the end of pregnancy, without any data or
history of PE. Exclusion criteria involved patients with
diabetes mellitus, gestational diabetes mellitus, renal dis-
eases, chronic hypertension, infectious diseases, autoim-
mune diseases, and chronic diseases in general.
The Hospital Ethics Committee approved this study
and written consent was obtained from all women.
Decidual leukocytes isolation and Flow cytometry
In order to isolate leukocytes from the decidua and to
characterize NK cells, tissue samples were processed as
described by Rieger et al [19], and Arcuri et al [29],
with minor modifications. Briefly, decidual tissues were
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extensively washed (at least three times) in sterile PBS
solution to eliminate any possible blood contamination;
and were then trimmed, minced and digested with 0.1%
(w/v) collagenase type IV (Sigma Chemical, St. Louis,
MO, USA) and 0.02% (w/v) hyaluronidase type I-S
(Sigma Chemical, St. Louis, MO, USA) in PBS for 1 h at
37°C under gentle agitation. The cell suspension was fil-
tered through a 70 μm sieve (Becton Dickinson Lab-
ware, Franklin Lakes, NJ, USA), washed in PBS and
layered on an equal volume of Ficoll Hypaque (Sigma
Chemical, St. Louis, MO, USA) at room temperature for
density gradient centrifuga t i o n( 2 5m i na t6 0 0g ) .C e l l s
were collected from the interface, washed and sus-
pended in RPMI 1640, supplemented with 10% FCS,
100 IU/mL penicillin, 100 IU/mL streptomycin and 0.25
μg/mL amphotericin B (Gibco BRL, Grand Island, NY,
USA).
Cells were labeled by direct staining with monoclonal
antibodies using single, double or triple color immuno-
fluorescence staining: CD3 [HIT3a; FITC] and CD16
[DJ130c; FITC] from Santa Cruz (Santa Cruz, CA,
USA); CD56 [N-CAM clone MEM 188; Phycoerythrin]
a n dC D 9[ O K T 3 ;F I T C ]f r o me - B i o s c i e n c e( S a nD i e g o ,
CA, USA). For three-color staining we used a third anti-
body for CD3 [clone SK7; PerCP] from Becton Dickin-
son (San Jose, CA, USA). 1 × 10
6 cells/mL in PBS/0.1%
sodium azide (300 μL/sample) were incubated with 10
or 20 μL of the appropriate monoclonal antibody for
30 min at 4°C in the dark. After two washes with PBS/
0.1% sodium azide and once with PBS, cells were resus-
pended and fixed with PBS containing 1% paraformalde-
hyde for 20 min at 4°C in the dark. After one wash
with PBS, cells were resuspended in PBS and analyzed
on a Becton Dickinson FACSCalibur Flow cytometer.
In order to characterize more closely the decidual leu-
kocyte population isolated and to establish qualitative
differences in the subset markers between decidual and
peripheral NK cells, using two-color staining the percen-
tage of CD56
+CD9
+ cells was compared with the same
region in peripheral blood mononuclear cells (PBMC).
A further characterization was done using triple-color
immunofluoresce staining, CD3
- cells were gated and
the CD56
+CD9
+ expression was analyzed in this gate to
avoid CD3
+CD56
+ contamination in the analysis of the
CD9 marker.
PBMC were obtained from healthy pregnant and non-
pregnant women, by Ficoll Hypaque (Sigma Chemical,
St. Louis, MO, USA) gradient and stained using the pro-
cedure described above.
Data were analyzed using BD Cell Quest™Software
(San Jose, CA, USA). The percentage of CD3
+ (mature
T lymphocytes), CD56
+ and CD3
-/CD56
+CD16
-/+ (NK
cells population) was established by delineating regions
around the lymphocyte cluster.
KIR genotyping
DNA was extracted from peripheral blood of PE and
control groups using a standard salting out procedure.
KIR genes were genotyped by the presence or absence
of each gene locus, using a low-resolution PCR-SSP
commercial typing kit, following the manufacturers’
instructions (Miltenyi Biotec, Bergisch Gladbach,
Germany). We determined the KIR genotypes responsi-
b l ef o rt h ei n h i b i t o r yf u n c t i o n s( 2DL1, 2DL2, 2DL3,
2DL4, 2DL5, 3DL1, 3DL2, 3DL3), the activating signals
(2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DS1)a n dt h et w o
pseudogenes (2DP1 and 3DP1). The amplification pro-
ducts were electrophoresed on 2% agarose gels contain-
ing ethidium bromide, and visualized under ultraviolet
light. The presence of each KIR gene was detected as a
band of the expected size. Individuals were determined
negative for a KIR gene when a band of the expected
size was absent and the control band was present. For
the assessment of a given genotype, KIR2DS4 full length
(ins) and deletion (del) variants were assigned positive
when either or both variants were detected; whereas
when both variants were absent the subject was labeled
as 2DS4 negative.
Statistics
The decidual leukocyte population was analyzed by Stu-
dent’s t-test. If the samples did not show a normal dis-
tribution, a non-parametric test was used (Mann
Whitney’s U-test). The p values lower than or equal to
0.05 were taken as significant.
Genotype frequency was determined by direct count-
ing. Genotype frequency comparisons were made by a
two-sided Fisher’s exact test; when the p value was less
than 0.05 we adopted a Bonferroni correction (pc)f o r
multiple comparisons. The odds ratio (OR) and 95%
confidence interval (CI) were calculated. The sample
size required for an alpha of 0.05 and 80% of statistical
power was calculated in each group.
All statistical analyses were performed in Prism 5
(GraphPad Software, Inc., La Jolla, CA, USA) for Windows.
Results
Flow cytometry of decidual leukocytes
The cell surface markers and proportion of isolated
leukocytes from third trimester decidual tissue are
shown in Figure 1 and Table 1, respectively. Figure 1A,
E, H and 1L show the negative control cell staining. The
classic markers for NK cells, CD56
+CD3
- (16.1% Figure
1B); and CD56
+CD16
+/- (1.6% Figure 1C) in the decidua
were compared with those obtained from the same
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1J). The phenotype found in leukocytes from the
decidua was similar to the CD56
+ CD16
- subpopulation
in PBMC however, the CD56
+ CD16
+ subpopulation
was not found in the decidua. Double positive cells were
found for CD56 and CD9 markers in decidual leuko-
cytes and PBMC, using two-color staining (Figure 1D,
upper right quadrant and Figure 1K, upper right quad-
rant). However, when we used three-color staining
(Figures 1E-G and 1L-N), 87% of the CD3
- CD56
+ sub-
population in the decidua (Figure 1F, R1) was CD9
+
(Figure 1G). In contrast, 98% of the same subpopulation
in PBMC (Figure 1M, R2) was negative for the CD9
marker (Figure 1N).
The classic markers for NK cells (CD3
-CD56
+)w e r e
detected in a similar percentage in the control and PE
decidual tissue (20.66 ± 9.49% vs 21.13 ± 12.79% respec-
tively; p > 0.05) (Table 1). The subset-markers, CD56
Figure 1 Flow cytometry analysis of decidual leukocytes. Comparison of typical subset-markers of NK cells (CD3
-,C D 5 6
+,C D 1 6
+/-) and the
non-typical dNK cells marker (CD9
+). A-D) Representative FACS for two-color staining for decidual leukocytes. E-G) Representative FACS for three-
color staining for decidual leukocytes. H-K) Representative FACS two-color staining for peripheral blood mononuclear cells (PBMC). L-M)
Representative FACS three-color staining for PBMC. A, E, H, L) negative cells; B, I) upper left quadrants (UL): CD56
+ CD3
- cells; C, J) UL: CD56
+
CD16
- cells; upper right quadrants (UR): CD56
+ CD16
+ cells; D, K) UR: CD56
+CD9
+ cells. F, M) R1 and R2, gate for CD3
- cells; G, N) CD56
+CD9
+/-
expression on CD3
- cells.
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-/+ and CD56
+CD9
+ remained similar between
both groups (p > 0.05) (Table 1).
Interestingly, significant differences in the proportion
of CD3
+ cells between PE patients and the control
group were found. A decreased percentage of CD3
+
cells in the PE group were observed as compared with
the control group (30.95 ± 15.01% vs 54.15 ± 17.76%,
respectively; p = 0.007) (Table 1).
KIR gene frequencies
To establish KIR gene frequencies, KIR genotyping was
performed in women with PE and controls (Table 2). Fra-
mework genes (2DL4 and 3DL3), and the two pseudogenes
(2DP1, 3DP1) were detected in 100% of women from both
groups. The 3DL2, 2DL1, 3DL1,a n d2DL3 genes were not
found in all individuals (90.7-98.9%). The lowest frequency
in both groups was for the 2DS3 gene (<21%).
The frequencies of KIR2DL2 (control, 61.6% vs PE,
43.3%;p= 0.017, OR = 0.47, 95% CI = 0.26 to 0.86; pc
> 0.05) and 2DL5 B (control, 64.0% vs PE, 48.9%; p =
0.049, OR = 0.54, 95% CI = 0.23 to 0.98; pc >0 . 0 5 )
were lower but not significantly different in the PE
group as compared to control group (Table 2). No asso-
ciation for the activating KIR genes (2DS1, 2DS2, 2DS3,
2DS4 del, 2DS4 ins, 2DS5 and 3DS1) between groups
was found. No significant differences were observed in
a n ys i n g l eK I Rg e n ef r e q u e n c ya f t e rw ea d o p t e dt h e
Bonferroni correction.
KIR genotype profiles
Fifty-seven combinations of KIR genes were found (Fig-
u r e2 ) .T h eg e n o t y p e s( G )w i t hal o w e rn u m b e ro fK I R
genes (G. 48 to G. 57) had at least one activating gene
and six or seven inhibitory genes. Genotypes 23, 52 and
56 were detected in high frequencies (10% to 15.6%),
whereas the rest of the genotypes were found in low fre-
quencies (0%-8.3%).
Genotypes 42 and 53 were more prevalent but not sig-
nificantly different in the control group as compared
with the PE group (pc > 0.05); both genotypes were
characterized by the presence of the KIR2DL2 gene.
Genotype 52 (KIR2DL2 negative) was two fold more fre-
quent in the PE group than in the control one, but this
difference was not significant.
The ratios of activating to inhibitory (Act/Inh) genes
ranged from 0.2 to 1.1. No significant differences were
observed in the individual ratios between groups. In
order to further analyze these data, we grouped the
ratios into 2 range categories: 0.2 to 0.5 (more inhibi-
tory range) and 0.6 to 1.1 (more activating range)
(Table 3).
With this analysis we observed that the PE women fall
more frequently (45.5%) into the inhibitory range cate-
gory than controls women (31.3%) and the controls
women fall more frequently (68.6%) in the activating
range as compared to PE group (54.4%), however this
difference was not significant (p = 0.05, OR = 0.54, 95%
IC = 0.29 to 1.013).
Discussion
Several studies indicate that dNK cells have a major role
in implantation and placental development; alterations
Table 2 Frequencies of KIR genes
KIR gene Controls (n = 86) PE (n = 90)
Inhibitory
2DL1 96.5 98.9
a2DL2 61.6 43.3
2DL3 94.2 95.6
2DL4 100.0 100.0
2DL5 all 61.6 47.8
2DL5 A 59.3 50.0
b2DL5 B 64.0 48.9
3DL1 90.7 93.3
3DL2 97.7 95.6
3DL3 100.0 100.0
Activating
2DS1 58.1 47.8
2DS2 48.8 36.7
2DS3 20.9 18.9
2DS4 del 65.4 54.1
2DS4 ins 75.3 76.5
2DS5 53.3 43.3
3DS1 52.3 48.9
Pseudogenes
2DP1 100.0 100.0
3DP1 100.0 100.0
Values are presented as percentage.
a p = 0.017, OR = 0.47, 95% CI = 0.26 to 0.86; pc > 0.05.
b p = 0.049, OR = 0.54, 95% CI = 0.23 to 0.98; pc > 0.05.
The p values were corrected for 19 comparisons using the Bonferroni correction.
Table 1 Proportion of decidual leukocytes analyzed by
Flow cytometry
Decidual lymphocyte
subset
Controls
(n = 10)
PE (n = 9) p
CD3
+ (%) 54.15 ± 17.76 30.95 ± 15.01 0.007
a
CD56
+ (%) 21.70 ± 10.35 23.24 ± 12.24 NS
CD3
+ CD56
+ (%) 2.34 ± 1.55 2.40 ± 2.05 NS
CD3
-CD56
+ (%) 20.66 ± 9.49 21.13 ± 12.79 NS
CD56
+CD16
- (%) 19.09 ± 9.49 21.41 ± 12.36 NS
CD56
+CD16
+ (%) 1.65 ± 1.17 2.81 ± 4.53 NS
CD56
+CD9
+ (%) 15.68 ± 4.88 18.87 ± 8.7 NS
Comparison of the proportion of decidual leukocytes between healthy
pregnant women (controls) and women with preeclampsia (PE) using two-
color immunofluorescence.
Values are presented as mean ± standard deviation; NS, No significant
difference; (%) percentage of cells bearing a particular set of subset markers.
a p < 0.05.
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with PE [11,25,30]. There is growing evidence that the
clinical features of PE are generated either by defective
placentation during early pregnancy and/or by a distinct
increase in the systemic inflammatory response in the
second part of pregnancy [31,32].
There is agreement on the presence of NK cells in
decidual tissue at the earliest stages of pregnancy, but
there are conflicting reports about their presence at the
third trimester of gestation [5-8,33,34]. In this study we
found a high percentage of CD3
-CD56
+ cells in the
decidua of women at the third trimester of pregnancy, in
agreement with previous investigations in which NK cells
have been found and isolated from deciduas at term [5-8].
This is the first demonstration that this population shares
the same phenotype as the dNK cells detected in the first
trimester of gestation (CD56
+ CD16
- and CD9
+) [14].
The CD9 marker has been proposed as a specific mar-
ker for dNK cells, it has been observed exclusively
expressed in NK cells isolated from decidua in early
g e s t a t i o nb u tn o ti np N Kc e l l s[ 1 0 ] .I np l a c e n t a ,i th a s
been detected by immunohistochemistry on extravillous
trophoblast cell columns of first trimester, but not in
the third trimester [35]. We found in the CD3
- gate,
double positive cells for CD56 and CD9 markers in leu-
kocytes from decidua and not in PBMC, suggesting that
the CD3
-CD56
+ CD9
+ subpopulation found in the third
trimester of gestation in the decidua, is similar to that
found in early pregnancy. However, we also observed
CD9 positive cells in all isolated PBMC when we used
two-color staining flow cytometry and since not all
CD56
+ cells in PBMC lack expression of CD3, there will
b eap o s s i b i l i t yt h a tt h eC D 5 6
+CD9
+ cells were CD3
+
Figure 2 KIR genotype distribution in control and preeclamptic women. KIR genotype distribution and percentage (%) of women
displaying each genotype in healthy women (Controls) and women with preeclampsia (PE). Shaded boxes represent the presence of the
inhibitory genes (2DL1, 2DL2, 2DL3, 2DL4, 2DL5all, 2DL5A, 2DL5B, 3DL1, 3DL2, 3DL3), activating (2DS1, 2DS2, 2DS3, 2DS4 del, 2DS4 ins, 2DS5, 3DS1)
and pseudogenes (2DP1, 3DP1). White boxes indicate the absence of KIR gene. Dark boxes indicate the presence of KIR gene. Dashed boxes
indicate that the genotype was assigned when either 2DS4 ins and 2DS4 del variants were detected. The total number of KIR genes in each
genotype is indicated, as well as the numbers of activating (S) and inhibitory (L) genes. Ratios of the activating to inhibitory genes are showed
in the right column. The p values less than 0.05 were corrected for 57 comparisons using the Bonferroni correction.
a p = 0.012, OR = 0.067, 95%
IC 0.004 to 1.204; pc > 0.05
b p = 0.03, OR = 0.124, 95% IC 0.015 to 1.028; pc > 0.05.
Table 3 Activating to inhibitory balance
Range Act/Inh Frequency (%)
Controls
Frequency (%)
PE
(n = 86) (n = 90)
Activating range: 0.6-1.1 68.6 54.4
Inhibitory range: 0.2-0.5 31.3 45.5
Ratio numbers of activating to inhibitory (Act/Inh) KIR genes between controls
and women with preeclampsia (PE). 0.2 to 0.5 (inhibitory range) and 0.6 to 1.1
(activating range).
p = 0.05, OR = 0.54, 95%CI 0.29 to 1.013.
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has been reported during infectious conditions [36].
This observation is clarified when we used three-color
staining flow cytometric analysis, because all NK cells in
PBMC were negative for CD9.
The ligand for murine CD9 is the pregnancy specific
glycoprotein (PSG) which concentration increases expo-
nentially in plasma until the term of pregnancy. The
CD9 ligand has been involved in the production of cyto-
kines contributing to a successful pregnancy [10,37].
According to Abadía-Molina et al, the possible role of
term decidual leukocytes is related to placental detach-
ment, cytokine production and normal delivery [6].
Thus, the presence of CD9+ dNK cells at term preg-
nancy could be of physiological relevance.
The precise composition of decidual leukocytes in PE
women has remained unclear due to diverse difficulties
such as different sources of decidual tissue (placental
bed or attached to the placenta) and the various meth-
ods used for their characterization (Flow cytometric
analysis and immunohistochemistry) [20]. The Flow
cytometric analysis used in this study overcomes this
problem providing a better quantification method that
can manage a high cell number. However, some dis-
crepancies have been found using this method. In the
present study the overall amount of each cell popula-
tion was quantified, while other studies previously
counted CD45 leukocytes. Wilczyński et al reported an
increase in the cytotoxic CD56
+CD16
+ population in
the PE group as compared with the control [38], while
Rieger et al found a decrease in the same population
[19]. In contrast, our work did not show any differ-
ences between the control and PE groups and we
found the cytotoxic population only in a small fraction
of the total CD56
+ cells. The cytokine-producer CD56
+CD16
- cells constituted the predominant subset
observed in this study, as it had been reported during
early pregnancy [14].
In our study, the observation of a decreased percen-
tage of CD3
+ cells in the PE group was an unexpected
finding. During early pregnancy, T cell lymphocytes
have been found in a minor leukocyte proportion in
decidua [30] and they predominate in the third trimester
of gestation, representing 50% to 60% of total leukocytes
in this tissue [2]. Our finding of reduced CD3
+ cells in
patients with PE is in agreement with recent reports of
decreased CD8
+ cell numbers [19] and T regulatory
cells [39], which suggests a possible role of T cells in PE
but requires further characterization.
Regarding NK cell function, it has been well estab-
lished that in addition to the total number of cells, NK
cell activity results from a balance between activating
and inhibitory receptors. Our results of KIR gene
frequencies are in accordance with previous studies of
KIR frequencies in Mexican population [40,41]. In the
present analysis we found a lower frequency of
KIR2DL2 gene that could suggest a predisposing effect
for PE. However, this difference was not statistically sig-
nificant. Interestingly, similar results have been reported
in recurrent miscarriage [42].
When the repertory of KIR genes was analyzed, we
found an increased percentage distribution of healthy
women with an activating genotype. Hiby et al,f o u n d
a strong association between the inhibitory genotype
(AA)a n dt h ep r e v a l e n c eo fP Ea n ds u g g e s t e dt h a tt h e
activating genotypes protect to PE [25]. Although
these genetic data support the notion that dNK cells
must be active in order to stimulate the appropriate
placental development and differentiation, other
researches have found contrasting results in a Japanese
population [43].
The widely divergent results obtained from dNK cells
at the end of pregnancy raises the necessity to demon-
strate their functions and implications in the pathogen-
esis of PE. Previous work has showed that women with
PE have an exaggerated proinflammatory response
mediated by pNK cells [44]; therefore it is mandatory to
explore the NK1/NK2 response in dNK cells from PE
patients. It is known that different factors, such as pla-
cental and fetal growth factors, and the local cytokine
and hormonal microenvironment modulate the activa-
tion of dNK cells throughout gestation. In addition,
stromal cells express receptors, ligands, or both, that
could interfere with the activity of dNK cells. Impor-
tantly, KIRs are also expressed in T cells; e.g., T cyto-
toxic cells [45]. Moreover KIR expression could change
throughout gestation [46].
Conclusion
In conclusion, we demonstrated the persistence of dNK
cells in PE and control women at the third trimester of
pregnancy; these dNK cells had a similar phenotype
(CD56
+,C D 3
-,C D 1 6
-,C D 9
+) to those found during
early pregnancy. The persistence of this subset until the
end of pregnancy suggests that they may be of physiolo-
gical relevance throughout pregnancy. The predomi-
nance of a KIR inhibitory balance in the PE group could
be associated to the physiopathology of PE, but suggests
that KIR repertory is not the only determinant factor
predisposing to PE.
List of abbreviations
CI: confidence interval; dNK: decidual NK cells; G: genotype; HLA:
histocompatibility leukocyte antigens; KIR: killer cell immunoglobulin like
receptors; NK: Natural Killer cells; OR: odds ratio; PBMC: peripheral blood
mononuclear cells; PE: preeclampsia; PLGF: placental growth factor; pNK:
peripheral NK cells.
Sánchez-Rodríguez et al. Reproductive Biology and Endocrinology 2011, 9:8
http://www.rbej.com/content/9/1/8
Page 7 of 9Acknowledgements
This study was supported by CONACyT-México; grant number 46759-Q and
grants PAPIIT IN219710-2 and PAIP 6190-08, from UNAM. EN S-R, is a student
of the Doctorate in Biomedical Sciences (UNAM) and received a fellowship
(202794) from CONACyT-México. The authors want to thank E. Rivera for her
help in the Flow cytometric analysis. The generous donation of biological
samples by patients and control volunteers are gratefully acknowledged. We
are grateful to the medical staff from the Hospital “Castelazo Ayala”, IMSS, for
their assistance in the diagnosis of patients and collecting samples. The
authors want to thank Dr. I. Camacho-Arroyo and C. Álvarez-Delgado for
proofreading the manuscript.
Author details
1Facultad de Química, Departamento de Biología, Universidad Nacional
Autónoma de México. Ciudad Universitaria, Coyoacán 04510, México, D.F.,
México.
2Servicio de Complicaciones Hipertensivas, UMAE de Ginecología y
Obstetricia “Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social,
México, D.F., México.
3Departamento de Inmunología, Instituto de
Investigaciones Biomédicas, UNAM, Mexico, D.F., México.
4Departamento de
Transplantes, Instituto Nacional de Ciencias Médicas y de la Nutrición
“Salvador Zubirán”, México, D.F., México.
5Servicio de Genética, Hospital
General de México/Facultad de Medicina, UNAM, México, D.F., México.
Authors’ contributions
ENSR and MC participated in the design of the study. ENSR performed the
experiments, analyzed the data and wrote the manuscript. SNS helped in
collecting and processing biological samples. JFRA and CM diagnosed the
patients and analyzed the clinical data. The data and the manuscript were
analyzed and reviewed by CAMR, EO, JG, AC and MC. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 9 September 2010 Accepted: 19 January 2011
Published: 19 January 2011
References
1. Pijnenborg R, Vercruysse L, Hanssens M: The uterine spiral arteries in
human pregnancy: facts and controversies. Placenta 2006, 27:939-958.
2. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D: Granulated
lymphocytes in human endometrium: histochemical and
immunohistochemical studies. Human Reprod 1991, 6:791-798.
3. King A, Loke YW: On the nature and function of human uterine granular
lymphocytes. Immunol Today 1991, 12:432-435.
4. Moffet-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002,
2:656-663.
5. Abadía-Molina AC, Ruiz C, Montes MJ, King A, Loke YW, Olivares EG:
Immune phenotype and cytotoxic activity of lymphocytes from human
term decidua against trophoblast. J Reprod Immunol 1996, 31:109-123.
6. Abadía-Molina AC, Ruiz C, King A, Loke YW, Olivares EG: Lymphocytes of
human term decidua decrease cell adhesion to a plastic substrate. Hum
Reprod 1997, 12:2393-2398.
7. Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, Kanhai HH,
Roelen DL, Claas F: Comparison of decidual leukocytes following
spontaneous vaginal delivery and elective cesarean section in
uncomplicated human term pregnancy. JR e p r o dI m m u n o l2004, 62:125-137.
8. Poehlmann TG, Schaumann A, Busch S, Fitzgerald JS, Aguerre-Girr M,
Le-Bouteiller P, Schleussner E, Markert UR: Inhibition of term decidual NK
cell cytotoxicity by soluble HLA-G1. Am J Reprod Immunol 2006,
56:275-285.
9. Williams PJ, Searle RF, Robson SC, Innes BA, Bulmer JN: Decidual leucocyte
populations in early to late gestation normal human pregnancy. J Reprod
Immunol 2009, 82:24-31.
10. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F,
Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human
decidual natural killer cells are a unique NK cell subset with
immunomodulatory potential. J Exp Med 2003, 198:1202-1212.
11. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-
Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yuykin V,
Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O: Decidual NK
cells regulate key developmental processes at the human fetal-maternal
interface. Nat Med 2006, 12:1065-1074.
12. Di Santo JP: Functionally distinct NK-cell subsets: developmental origins
and biological implications. Eur J Immunol 2008, 38:2948-2951.
13. Mselle TF, Meadows SK, Eriksson M, Smith JM, Shen L, Wira CR, Sentman CL:
Unique characteristics of NK cells throughout the human female
reproductive tract. Clin Immunol 2007, 124:69-76.
14. Manaster I, Mandelboim O: The unique properties of human NK cells in
the uterine mucosa. Placenta 2008, 29(Suppl A):60-66.
15. Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL: Evidence for immune cell
involvement in decidual spiral arteriole remodeling in early human
pregnancy. Am J Pathol 2009, 174:1959-1971.
16. Stallmach T, Hebisch G, Orban P, Lü X: Aberrant positioning of
trophoblast and lymphocytes in the feto-maternal interface with pre-
eclampsia. Virchows Arch 1999, 434:207-211.
17. Wilczyński JR, Tchórzewski H, Banasik M, Głowacka E, Wieczorek A,
Lewkowicz P, Malinowski A, Szpakowski M, Wilczyński J: Lymphocyte
subset distribution and cytokine secretion in third trimester decidua in
normal pregnancy and preclampsia. Eur J Obstet Gynecol Reprod Biol 2003,
109:8-15.
18. Eide IP, Rolfseng T, Isaksen CV, Mecsei R, Roald B, Lydersen S, Salvesen KA,
Harsem NK, Austgulen R: Serious foetal growth restriction is associated
with reduced proportions of natural killer cells in decidua basalis.
Virchows Arch 2006, 448:269-276.
19. Rieger L, Segerer S, Bernar T, Kapp M, Majic M, Morr AK, Dietl J,
Kämmerer U: Specific subsets of immune cells in human decidua differ
between normal pregnancy and preclampsia - a prospective
observational study. Reprod Biol Endocrinol 2009, 23:132-142.
20. Williams PJ, Bulmer JN, Searle RF, Innes BA, Robson SC: Altered decidual
leucocyte populations in the placental bed in pre-eclampsia and foetal
growth restriction: a comparison with late normal pregnancy.
Reproduction 2009, 138:177-184.
21. Khong TY: Immunohistologic study of the leukocytic infiltrate in
maternal uterine tissues in normal and preeclamptic pregnancies at
term. Am J Reprod Immunol Microbiol 1987, 15:1-8.
22. Trowsdale J, Barten R, Haude A, Stewart AC, Beck S, Wilson M: The
genomic context of Natural Killer receptor extended gene families.
Immunol Rev 2001, 181:20-38.
23. Bashirova A, Martin P, Mc Vicar W, Carrington M: The killer
immunoglobulin like receptor gene cluster: Tuning the genome for
defense. Annu Rev Genomics Hum Genet 2006, 7:277-300.
24. Carrington M, Martin MP: The impact of variation at the KIR gene cluster
on human disease. Curr Top Microbiol Immunol 2006, 298:225-257.
25. Hiby SE, Walker JJ, O’shaughnessy KM, Redman CW, Carrington M,
Trowsdale J, Moffet A: Combinations of maternal KIR and fetal HLA-C
genes influence the risk of preeclampsia and reproductive success. J Exp
Med 2004, 200:957-965.
26. ACOG Committee on Practice Bulletins-Obstetrics: ACOG practice bulletin.
Diagnosis and management of preeclampsia and eclampsia. Number 33,
January 2002. Obstet Gynecol 2002, 99:159-167.
27. Tuffnell DJ, Shennan AH, Waugh JJ, Walker JJ: The management of severe
pre-eclampsia/eclampsia. RCOG Guidelines 2006, Guideline 10(A):1-11.
28. Romero-Arauz JF: Epidemiología, clasificación y factores de riesgo en
preeclampsia. Preeclampsia. Enfermedades hipertensivas del embarazo
Mexico: McGrawHill; 2009, 1-15.
29. Arcuri F, Cintorino M, Carducci A, Papa S, Riparbelli MG, Mangioni S, Di
Blasio AM, Tosi P, Viganò P: Human decidual natural killer cells as a
source and target of macrophage migration inhibitory factor.
Reproduction 2006, 131:175-182.
30. King A, Burrows T, Verma S, Hiby S, Loke YW: Human uterine lymphocytes.
Hum Reprod Update 1998, 4:480-485.
31. Redman CW, Sargent IL: Pre-eclampsia, the placenta and the maternal
systemic inflammatory response–a review. Placenta 2003, 24(Suppl
A):21-27.
32. Borzychowski AM, Croy BA, Chan WL, Redman CW, Sargent IL: Changes in
systemic type 1 and type 2 immunity in normal pregnancy and pre-
eclampsia may be mediated by natural killer cells. Eur J Immunol 2005,
35:3054-3063.
33. Haller H, Radillo O, Rukavina D, Tedesco F, Candussi G, Petrović O, Randić L:
An immunohistochemical study of leucocytes in human endometrium,
first and third trimester basal decidua. J Reprod Immunol 1993, 23:41-49.
Sánchez-Rodríguez et al. Reproductive Biology and Endocrinology 2011, 9:8
http://www.rbej.com/content/9/1/8
Page 8 of 934. Vargas ML, Sántos JL, Ruiz C, Montes MJ, Alemán P, García-Tortosa C,
García-Olivares E: Comparison of the proportions of leukocytes in early
and term decidua. Am J Reprod Immunol 1993, 29:135-140.
35. Hirano T, Higuchi T, Ueda M, Inoue T, Kataoka N, Maeda M, Fujiwara H,
Fujii S: CD9 is expressed in extravillous trhophoblast in association with
integrin alpha3 and integrin alpha5. Mol Hum Reprod 1999, 5:162-167.
36. Tohami T, Drucker L, Radnay J, Shapira H, Lishner M: Expression of
tetraspanins in peripheral blood leukocytes: a comparison between
normal and infectious conditions. Tissue Antigens 2004, 64:235-242.
37. Waterhouse R, Ha C, Devksler GS: Murine CD9 is the receptor for
pregnancy-specific glycoprotein 17. J Exp Med 2002, 195:277-282.
38. Wilczyński JR, Tchórzewski H, Głowacka E, Banasik M, Lewkowicz P,
Szpakowski M, Zeman K, Wilczyński J: Cytokine secretion by decidual
lymphocytes in transient hypertension of pregnancy and pre-eclampsia.
Mediators Inflamm 2002, 11:105-111.
39. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T,
Shiozaki A, Rolinski J, Saito S: Proportion of peripherals blood and
decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin
Exp Immunol 2007, 149:139-145.
40. Gutiérrez-Rodríguez ME, Sandoval-Ramírez L, Díaz-Flores M, Marsh SG,
Valladares-Salgado A, Madrigal JA, Mejía-Aranguere JM, García CA, Huerta-
Zepeda A, Ibarra-Cortés B, Ortega-Camarillo C, Cruz M: KIR gene in ethnic
and Mestizo populations from Mexico. Hum Immunol 2006, 67:85-93.
41. Contreras G, Aláez C, Murguía A, García D, Flores H, Gorodezky C:
Distribution of the killer cell immunoglobulin-like receptors in Mexican
Mestizos. Tissue Antigens 2007, 69(Suppl 1):125-129.
42. Flores AC, Marcos CY, Paladino N, Arruvito L, Williams F, Middleton D,
Fainboim L: KIR receptors and HLA-C in the maintenance of pregnancy.
Tissue Antigens 2007, 69(Suppl 1):112-113.
43. Saito S, Takeda Y, Sakai M, Nakabayahi M, Hayakawa S: The incidence of
pre-eclampsia among couples consisting of Japanese women and
Caucasian men. J Reprod Immunol 2006, 70:93-98.
44. Borzychowsky AM, Croy BA, Chan WL, Redman CW, Sargent IL: Changes in
systemic type 1 and type 2 immunity in normal pregnancy and pre-
eclampsia may be mediated by natural killer cells. Eur J Immunol 2005,
35:3054-3063.
45. Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA,
Claas FH: Expression of NK cell receptor son decidual T cells in human
pregnancy. J Reprod Immunol 2009, 80:22-32.
46. Sharkey AM, Gardner L, Hiby S, Farrell L, Apps R, Masters L, Goodridge J,
Lathbury L, Stewart CA, Verma S, Moffett A: Killer-Ig-like receptor
expression in uterine NK cells is biased toward recognition of HLA-C
and alters with gestational age. J Immunol 2008, 181:39-46.
doi:10.1186/1477-7827-9-8
Cite this article as: Sánchez-Rodríguez et al.: Persistence of decidual NK
cells and KIR genotypes in healthy pregnant and preeclamptic women: a
case-control study in the third trimester of gestation. Reproductive Biology
and Endocrinology 2011 9:8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sánchez-Rodríguez et al. Reproductive Biology and Endocrinology 2011, 9:8
http://www.rbej.com/content/9/1/8
Page 9 of 9